Encube Ethicals Files for Rs 3,000 Crore IPO with Sebi
Encube Ethicals, a Mumbai-based specialty pharmaceutical company founded in 1995, has filed preliminary papers with Sebi for a Rs 3,000 crore Initial Public Offering (IPO). The IPO is an offer for sale by promoter Mehul Madhusudan Shah and shareholder Frontier Investment Holdings, with proceeds going to them rather than the company. Encube operates globally, serving 50 countries with accredited manufacturing facilities and reported Rs 1,848.7 crore revenue and Rs 436.7 crore net profit in FY26. The shares will be listed on BSE and NSE.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (52/100). Lens Score 48/100.
Outlets measured: freepressjournal, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–55/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 3 Aug, 10:30 am. Other outlets followed.
- 1